Bain Capital Specialty BCSF will release its quarterly earnings report on Monday, 2025-05-05. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Bain Capital Specialty to report an earnings per share (EPS) of $0.47.
Investors in Bain Capital Specialty are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Earnings Track Record
During the last quarter, the company reported an EPS beat by $0.05, leading to a 3.25% increase in the share price on the subsequent day.
Stock Performance
Shares of Bain Capital Specialty were trading at $15.01 as of May 01. Over the last 52-week period, shares are down 8.81%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
Analysts' Perspectives on Bain Capital Specialty
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Bain Capital Specialty.
With 4 analyst ratings, Bain Capital Specialty has a consensus rating of Neutral. The average one-year price target is $17.5, indicating a potential 16.59% upside.
Understanding Analyst Ratings Among Peers
The analysis below examines the analyst ratings and average 1-year price targets of Virtus Inv, P10 and WisdomTree, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
- Analysts currently favor an Underperform trajectory for Virtus Inv, with an average 1-year price target of $183.14, suggesting a potential 1120.12% upside.
- Analysts currently favor an Outperform trajectory for P10, with an average 1-year price target of $14.0, suggesting a potential 6.73% downside.
- Analysts currently favor an Sell trajectory for WisdomTree, with an average 1-year price target of $8.5, suggesting a potential 43.37% downside.
Comprehensive Peer Analysis Summary
Within the peer analysis summary, vital metrics for Virtus Inv, P10 and WisdomTree are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.
| Company | Consensus | Revenue Growth | Gross Profit | Return on Equity |
|---|---|---|---|---|
| Acadian Asset Management | Neutral | 27.90% | $91.70M | 4047.62% |
| Virtus Inv | Underperform | -6.69% | $126.21M | 3.20% |
| P10 | Outperform | 34.80% | $45.59M | 1.51% |
| WisdomTree | Sell | 21.85% | $57.81M | 6.76% |
Key Takeaway:
Bain Capital Specialty ranks at the top for Revenue Growth and Gross Profit among its peers. It is in the middle for Return on Equity.
About Bain Capital Specialty
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan among others.
Breaking Down Bain Capital Specialty's Financial Performance
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Decline in Revenue: Over the 3 months period, Bain Capital Specialty faced challenges, resulting in a decline of approximately -23.91% in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Bain Capital Specialty's net margin excels beyond industry benchmarks, reaching 81.64%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Bain Capital Specialty's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 1.94%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.86%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Bain Capital Specialty's debt-to-equity ratio is below the industry average at 1.22, reflecting a lower dependency on debt financing and a more conservative financial approach.
To track all earnings releases for Bain Capital Specialty visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
